APA (7th ed.) Citation

A, K., Z, D., D, F., C, Z., A, S., YM, H., . . . JJ, A. (2023). LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function. JCI insight, 8(15), . https://doi.org/10.1172/jci.insight.167440

Chicago Style (17th ed.) Citation

A, Kumaraswamy, et al. "LSD1 Promotes Prostate Cancer Reprogramming by Repressing TP53 Signaling Independently of Its Demethylase Function." JCI Insight 8, no. 15 (2023). https://doi.org/10.1172/jci.insight.167440.

MLA (9th ed.) Citation

A, Kumaraswamy, et al. "LSD1 Promotes Prostate Cancer Reprogramming by Repressing TP53 Signaling Independently of Its Demethylase Function." JCI Insight, vol. 8, no. 15, 2023, https://doi.org/10.1172/jci.insight.167440.